Companies Funded
T3DC, The Texas Technology Development Center, began reviewing applications for funding in November 2009, focusing on early-stage, high-potential technology companies whose innovations in life and physical sciences provide exciting opportunities for economic success. T3DC is reviewing applications quarterly. We operate on a first-come, first-serve basis.
Metric Medical Devices Inc.
Metric Medical Devices, Inc.’s mission is to develop advanced orthopedic implant systems for musculoskeletal fixation. Metric develops, manufactures and is commercializing products to advance the standard of care in the treatment of disease and trauma. The orthopedic fracture and internal fixation market exceeds $2.6 billion annually for the foot and hand and is expected to exceed $4.6 billion annually by 2015 due to the growing related disorders of obesity, diabetes, and arthritis as well as the population’s increasing age and active lifestyle.
StemBioSys, LLC.
StemBioSys, LLC, develops and licenses novel, proprietary stem cell technologies to meet the promise of regenerative medicine in a surging global market. The company's first manufactured product is XC-marrow ECM™ , a unique extracellular matrix which provides a native three-dimensional environment for rapid expansion of stem cells derived from various sources including bone marrow, adipose tissue, umbilical cord blood and umbilical cord tissue. Compared with culture media currently in use, cells cultured on this next-generation ECM grow 7 to 10 times faster and maintain their stem cell qualities ("stemness") in unprecedented fashion.
StemBioSys technology also isolates and expands large and hitherto unrecognized quantities of pluri-potent, embryonic-like mesenchymal stem cells (MSCs) from human umbilical cord blood. Such cells can advance future stem cell applications in regenerating human tissues including nerve, muscle, skin, bone, adipose, cartilage, glandular cells and blood vessels.